2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Закрыть
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
505 0
SM ISO690:2012
CATAPANO, Alberico L., GRAHAM, Ian Maklim, NOI, Autori, IVANOV, Victoria. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. In: European Heart Journal, 2016, vol. 37, pp. 2999-3058. ISSN 0195-668X. DOI: https://doi.org/10.1093/eurheartj/ehw272
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
European Heart Journal
Volumul 37 / 2016 / ISSN 0195-668X

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

DOI:https://doi.org/10.1093/eurheartj/ehw272

Pag. 2999-3058

Catapano Alberico L.1, Graham Ian Maklim2, Noi Autori, Ivanov Victoria3
 
1 University of Milan,
2 Trinity College Dublin,
3 Moldavian Society of Cardiology
 
 
Disponibil în IBN: 27 iulie 2022


Rezumat

The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

Cuvinte-cheie
Cardiology, cardiovascular diseases, dyslipidemias, Europe, Humans, Risk, Sex Factors, societies, medical